AirAvant Medical

Curated by Signal

Developer of nasal seals for the treatment of obstructive sleep apnea

Overview

AirAvant is developing nasal seals for the treatment of mild to moderate obstructive sleep apnea. The product developed by the company called Bongo Rx does not require any power, assembly or disassembly. The company has received FDA approval for its product. The device consists of small valves which close during exhalation directing exhaled air through specifically designed vent holes to generate EPAP (Expiratory Positive Airway Pressure), thus keeping the airway open.

Key facts

Founded: 2018
Headquarters: Deerfield Beach, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Panorama Medicine
Provider of drug discovery platform for detecting RNA defects
Life Sciences TechnologyPhiladelphia, United States
Isowalk
Hardware and software platform for advanced mobility assistance
Life Sciences TechnologyLos Angeles, United States
MMUSA
Online e-commerce platform for fitness supplements
Life Sciences TechnologyCarson City, United States

About AirAvant Medical

What does AirAvant Medical do?

AirAvant is developing nasal seals for the treatment of mild to moderate obstructive sleep apnea.

Where is AirAvant Medical headquartered?

AirAvant Medical is headquartered in Deerfield Beach, United States.

When was AirAvant Medical founded?

AirAvant Medical was founded in 2018.

Which sector is AirAvant Medical in?

AirAvant Medical operates in Life Sciences Technology.

Who are AirAvant Medical's competitors?

Companies similar to AirAvant Medical include Panorama Medicine, Isowalk, and MMUSA.